Topics

• ANTITRUST

• Asset Management

• Digital Health

• Employee Benefits/ERISA

• Enforcement

• False Claims Act

• FDA REGULATORY

• Health Care

• Intellectual Property

• PRIVATE EQUITY

• TAX

Capital Insights

Analysis

• Podcast: Hedging with a Purpose: An Overview of Derivatives in Sustainable Finance
  (February 17, 2021)
• Chinese Government Introduces Rules Restricting Application of Foreign Laws
  (February 17, 2021)
• Back to the Future: New Executive Order Restarts Myanmar Sanctions
  (February 12, 2021)
• Podcast: Communist Chinese Military Companies Executive Order: Implications and Key Questions
  (February 11, 2021)
• President Biden’s Buy American Executive Order Signals Possible Heightened False Claims Act Risk for Government Contractors
  (February 11, 2021)
• IRS Issues Final Regulations on Deductions of Certain Settlement Payments to Governments
  (February 10, 2021)

News & Events

• Event: Outlook 2021 – Washington, D.C. Updates and Insights on Life Sciences and Health Care
  (February 25, 2021)
• In Law360, Margaux Hall Examines Drug Commercialization and Market Access Strategies in Light of Drug Pricing Regulatory Uncertainty Under the Biden Administration
  (February 16, 2021)
• In Managing Intellectual Property, IP Litigator Addresses Patent Eligibility Criteria Challenges
  (February 16, 2021)
• On BBC World Service Panel, Marta Belcher Discusses Cryptocurrency Regulation
  (February 10, 2021)
• In The New York Times, Craig Marcus Examines How Certain Winners are Cashing in on ‘Meme Stock’ Mania
  (February 9, 2021)